CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CytoGenix, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CytoGenix, Inc.
710 N. Post Oak Road
Suite 410
Phone: (713) 780-0806p:713 780-0806 Houston, TX  77024  United States Ticker: CYGXCYGX
This company is no longer actively traded on any major stock exchange.
Business Summary
CytoGenix, Inc. (CytoGenix) is a biopharmaceutical company whose primary focus is the development and commercialization of its technologies for identifying and silencing disease causing genes, expressing proteins for applications, such as vaccines and isolating nucleic acid-based anti-microbial compounds. The Company’s three technologies comprise: gene silencing techniques single-stranded deoxyribonucleic acid (ssDNA) applicable to genes from pathogenic organisms or selected genes from a patient to prevent the expression of harmful proteins, thereby preventing or ameliorating disease; a cell free process to produce large quantities of DNA (synDNA) for use in its own products and for sale to other biopharmaceutical or life science companies, and a methodology to isolate and characterize DNA-based drugs (Oligogenix), to which harmful bacteria have not developed immunity.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/200912/31/2008YesYes---

Industries
SIC Code Description
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Cy A.Stein 56 10/27/2010 1/1/2003
Chief Financial Officer Steven M.Plumb 50 9/11/2010 9/11/2010
Director John J.Rossi 62 11/11/2003 11/11/2003

Business Names
Business Name
BioEnergy, Inc.
CYGX
CYTOGENIX INC
CytoGenix, Inc.

General Information
Number of Employees: 3 (As of 12/31/2008)
Outstanding Shares: 169,404,590 (As of 5/14/2009)
Shareholders: 644
Stock Exchange: OTC
Federal Tax Id: 760484097
Fax Number: (830) 632-5944


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023